Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TRX-103 by Tr1X for Graft Versus Host Disease (GVHD): Likelihood of Approval
TRX-103 is under clinical development by Tr1X and currently in Phase II for Graft Versus Host Disease (GVHD). According to...